SCHEMBL22984359

SCHEMBL22984359

Cc1cn2c(C(=O)NCc3ccc4c(c3)C(=O)CO4)c(C)nc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 4/20 0.42
HPGD P15428 2/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 2/20 0.40
KDM4E B2RXH2 2/20 0.39
POLB P06746 3/20 0.37
MEN1 O00255 2/20 0.37
TSHR P16473 2/20 0.37
KMT2A Q03164 2/20 0.37
CHRM4 P08173 1/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
THRB P10828 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
BLM P54132 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22984356 0.83 HTT (0.55) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL18642142 0.82 CHRM4 (0.54) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL18642131 0.81 SMN1; SMN2 (0.57) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL22984280 0.81 LMNA (0.44) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL22984316 0.80 CHRM4 (0.49) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL22984330 0.80 HTT (0.47) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL22984296 0.80 HTT (0.47) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL16945294 0.80 HTT (0.48) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL22984371 0.80 HTT (0.48) HTTSMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL22984308 0.77 HTT (0.44) HTTSMN1; SMN2L3MBTL1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919888-B2 Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection UNIVERSITY OF NOTRE DAME DU LAC (US) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919888-B2 Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection BET1, BRD4, BRD3 HTT 4525/4885SMN1; SMN2 3362/4885L3MBTL1 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.